首页> 外国专利> RADIOLABELLED QUINOLINE AND QUINOLINONE DERIVATIVES AND THEIR USE IN DIAGNOSTIC METHOD AS METABOTROPIC GLUTAMATE RECEPTOR LIGANDS

RADIOLABELLED QUINOLINE AND QUINOLINONE DERIVATIVES AND THEIR USE IN DIAGNOSTIC METHOD AS METABOTROPIC GLUTAMATE RECEPTOR LIGANDS

机译:放射性标记的喹啉和喹啉酮衍生物及其在诊断方法中作为代谢型谷氨酸受体配体的用途

摘要

The present invention is concerned with radiolabelled quinoline and quinolinone derivatives according Formula (I-A)* or (I-B)* showing metabotropic glutamate receptor antagonistic activity, in particular mGlu1 receptor activity, and their preparation ; it further relates to compositions comprising them, as well as their use for marking and identifying metabotropic glutamate receptor sites and for imaging an organ. In a preferable embodiment, X represents O; R1 represents C1-6alkyl; cyclo3-12alkyl or (cycloC3-12alkyl)C1-6alkyl, wherein one or more hydrogen atoms in a C1-6alkyl-moiety or in a cycloC3-12alkyl-moiety optionally may be replaced by C1-6alkyloxy, aryl, halo or thienyl; R2 represents hydrogen; halo; C1-6alkyl or amino; R3 and R4 each independently represent hydrogen or C1-6alkyl; or R2 and R3 may be taken together to form -R2-R3-, which represents a bivalent radical of formula -Z4-CH2-CH2-CH2- or -Z4-CH2-CH2- with Z4 being O or NR11 wherein R11 is C1-6alkyl; and wherein each bivalent radical is optionally substituted with C1-6alkyl; or R3 and R4 may be taken together to form a bivalent radical of formula -CH2-CH2-CH2-CH2- ; R5 represents hydrogen; Y represents O; and aryl represents phenyl optionally substituted with halo. Most preferred are radiolabelled compounds in which the radioactive isotope is selected from the group of of 3H, 11C and 18F. The invention also relates to their use in a diagnostic method, in perticular for marking and identifying a mGluR1 receptor in biological material, as well as to their use for imaging an organ, in particular using PET.
机译:本发明涉及式(I-A)*或(I-B)*的放射性标记的喹啉和喹啉酮衍生物,其显示出代谢型谷氨酸受体拮抗活性,特别是mGlu1受体活性,及其制备方法;它进一步涉及包含它们的组合物,以及它们在标记和鉴定代谢型谷氨酸受体位点以及对器官成像中的用途。在一个优选的实施方案中,X表示O; R1代表C1-6烷基;环3-12烷基或(环C3-12烷基)C1-6烷基,其中C1-6烷基部分或环C3-12烷基部分中的一个或多个氢原子可任选地被C1-6烷氧基,芳基,卤素或噻吩基取代; R 2代表氢;光环; C 1-6烷基或氨基; R3和R4各自独立地表示氢或C1-6烷基;或R 2和R 3可以一起形成-R 2 -R 3-,其代表式-Z 4 -CH 2 -CH 2 -CH 2-或-Z 4 -CH 2 -CH 2-的二价基团,其中Z 4为O或NR 11,其中R 11为C 1。 -6烷基;其中每个二价基团任选被C 1-6烷基取代;或者R3和R4可以一起形成式-CH2-CH2-CH2-CH2-的二价基团; R5代表氢; Y代表O;芳基代表任选被卤素取代的苯基。最优选的是放射性标记的化合物,其中放射性同位素选自3H,11C和18F。本发明还涉及它们在诊断方法中的用途,特别是用于标记和鉴定生物材料中的mGluR1受体,以及它们在器官成像中的用途,特别是使用PET。

著录项

  • 公开/公告号NO330688B1

    专利类型

  • 公开/公告日2011-06-06

    原文格式PDF

  • 申请/专利权人 JANSSEN PHARMACEUTICA NV;

    申请/专利号NO20040004635

  • 申请日2004-10-27

  • 分类号C07D215/06;C07D215/14;A61K31/47;A61K31/4704;A61K31/4709;A61K31/473;A61K31/4741;A61K31/4743;A61K31/4745;A61K31/496;A61K31/497;A61K31/506;A61K31/5377;A61K31/541;A61K51;A61K51/04;A61P3/08;A61P9/10;A61P25;A61P25/02;A61P25/04;A61P25/08;A61P25/14;A61P25/16;A61P25/18;A61P25/22;A61P25/24;A61P25/28;A61P25/30;A61P31/18;A61P43;C07D215/18;C07D215/22;C07D215/26;C07D215/36;C07D215/38;C07D215/48;C07D215/50;C07D215/54;C07D215/60;C07D219/02;C07D221/10;C07D221/12;C07D221/16;C07D401/04;C07D401/06;C07D401/12;C07D405/04;C07D405/06;C07D405/12;C07D409/04;C07D409/06;C07D409/12;C07D413/12;C07D417/04;C07D453/06;C07D471/04;C07D491/048;C07D491/052;C07D495/04;C07D519;

  • 国家 NO

  • 入库时间 2022-08-21 18:05:10

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号